JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.74B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$8.51B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$6.03B |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$4.86B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.63B |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.02B |
| 3 |
Palantir
PLTR
|
+$2.14B |
| 4 |
Shopify
SHOP
|
+$2.1B |
| 5 |
Robinhood
HOOD
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.29% |
| 2 | Technology | 22.42% |
| 3 | Healthcare | 8.64% |
| 4 | Financials | 8.63% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5401
Luxfer Holdings
LXFR
$466M
| $154K | ﹤0.01% |
12,874
-16,103
| -56% | -$224K |
2016 Q1
40 quarters
|
|
5402
Virtus InfraCap US Preferred Stock ETF
PFFA
$2.38B
| $153K | ﹤0.01% |
7,532
+7,253
| +2,600% | +$156K |
2025 Q2
3 quarters
|
|
5403
ALPS Dynamic US Dividend Advantage ETF
RFDA
$78.2M
| $153K | ﹤0.01% |
2,482
| – | – |
2022 Q4
13 quarters
|
|
5404
Fidelity US Multifactor ETF
FLRG
$292M
| $153K | ﹤0.01% |
4,238
+2,392
| +130% | +$90.9K |
2025 Q1
4 quarters
|
|
5405
iShares Future Exponential Technologies ETF
XT
$4.04B
| $153K | ﹤0.01% |
2,320
+791
| +52% | +$56.2K |
2022 Q3
14 quarters
|
|
5406
CALL
BridgeBio Pharma
BBIO
$13.2B
| $153K | ﹤0.01% |
2,200
| – | – |
2024 Q4
5 quarters
|
|
|
5407
PUT
BridgeBio Pharma
BBIO
$13.2B
| $153K | ﹤0.01% |
2,200
-14,000
| -86% | -$1.01M |
2024 Q3
6 quarters
|
|
5408
Pacer Global Cash Cows Dividend ETF
GCOW
$3.4B
| $152K | ﹤0.01% |
3,321
+947
| +40% | +$42.4K |
2023 Q2
11 quarters
|
|
|
GSRFU
5409
GSR IV Acquisition Corp Units
GSRFU
| $152K | ﹤0.01% |
14,500
-500
| -3% | -$5.17K |
2025 Q3
2 quarters
|
|
|
BKCG
5410
BNY Mellon Concentrated Growth ETF
BKCG
$123M
| $151K | ﹤0.01% |
+4,571
| New | +$164K |
2026 Q1
0 quarters
|
|
5411
CALL
Omnicom Group
OMC
$20.3B
| $151K | ﹤0.01% |
2,000
+600
| +43% | +$46.5K |
2025 Q4
1 quarter
|
|
5412
RBB Bancorp
RBB
$441M
| $151K | ﹤0.01% |
7,078
-20,184
| -74% | -$433K |
2017 Q4
33 quarters
|
|
5413
Akebia Therapeutics
AKBA
$238M
| $151K | ﹤0.01% |
114,047
-79,979
| -41% | -$110K |
2017 Q4
33 quarters
|
|
5414
THOR Low Volatility ETF
THLV
$54M
| $150K | ﹤0.01% |
4,763
-12
| -0.3% | -$383 |
2025 Q3
2 quarters
|
|
5415
Invesco CurrencyShares Japanese Yen Trust
FXY
$461M
| $150K | ﹤0.01% |
2,613
-28,550
| -92% | -$1.67M |
2025 Q2
3 quarters
|
|
|
TTAM
5416
Titan America SA
TTAM
$2.47B
| $150K | ﹤0.01% |
10,523
+319
| +3% | +$5.45K |
2025 Q2
3 quarters
|
|
5417
Avantis US Mid Cap Value ETF
AVMV
$766M
| $150K | ﹤0.01% |
+2,062
| New | +$155K |
2026 Q1
0 quarters
|
|
5418
Saratoga Investment
SAR
$265M
| $150K | ﹤0.01% |
7,021
| – | – |
2024 Q3
6 quarters
|
|
|
SNXX
5419
Tradr 2X Long SNDK Daily ETF
SNXX
$2.71B
| $150K | ﹤0.01% |
+40,000
| New | +$196K |
2026 Q1
0 quarters
|
|
5420
Fidelity Hedged Equity ETF
FHEQ
$986M
| $149K | ﹤0.01% |
+5,151
| New | +$158K |
2026 Q1
0 quarters
|
|
|
BRHY
5421
BlackRock ETF Trust II iShares High Yield Active ETF
BRHY
$140M
| $149K | ﹤0.01% |
+2,974
| New | +$152K |
2026 Q1
0 quarters
|
|
5422
MasterCraft Boat Holdings
MCFT
$492M
| $149K | ﹤0.01% |
7,226
+578
| +9% | +$12.5K |
2017 Q4
33 quarters
|
|
5423
ProShares UltraShort Silver
ZSL
$76.7M
| $149K | ﹤0.01% |
+5,663
| New | +$142K |
2026 Q1
0 quarters
|
|
5424
Cornerstone Strategic Value Fund
CLM
$1.99B
| $148K | ﹤0.01% |
21,285
+18,253
| +602% | +$143K |
2025 Q4
1 quarter
|
|
5425
NVE Corp
NVEC
$541M
| $148K | ﹤0.01% |
2,279
-15,087
| -87% | -$1.02M |
2023 Q1
12 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2026 Portfolio in Review
As of Q1 2026, JP Morgan Chase held 8,085 positions worth $1.56T, down 2.2% from $1.59T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase deployed $90.5B of net new capital in Q1 2026, opening 727 new positions and adding to 3,199 existing holdings. Its largest new stake was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $8.63B trimmed.
- JP Morgan Chase's largest Q1 2026 buy was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $9.74B increase.
- JP Morgan Chase's biggest Q1 2026 reduction was Microsoft, cutting an estimated $8.63B.
- JP Morgan Chase fully exited CyberArk in Q1 2026, selling an estimated $307M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.56T portfolio in Q1 2026.
- JP Morgan Chase opened 727 new positions and closed 604 in Q1 2026.
- JP Morgan Chase's portfolio value fell 2.2% quarter-over-quarter to $1.56T.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.